MedTrace Logo

Urinary Incontinence Self-Screen for Healthy Aging

NCT03485872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2020-11-04

No results posted yet for this study

Summary

The purpose of this study is to increase awareness and timely treatment of urinary incontinence through a self-screening process. This is a 3 month study involving 2 activities; one taking place at the beginning of study and another 3 months later. Participants will be randomized into experimental and control groups. The experimental group will receive a demographic questionnaire, quality of life questionnaire, a questionnaire pertaining to urinary symptoms, information about how to self-screen for urinary incontinence and information regarding how to refer oneself to urinary incontinence resources. The control group will receive the demographic and quality of life questionnaires only. It is estimated that it will take participants 20-30 minutes to complete their package of questionnaires. After 3 months, the participants will receive a phone call inquiring into what actions they have taken regarding their urinary incontinence.

Conditions

Interventions

OTHER

Self-Screening and Referral Information

Urinary incontinence self-screening questionnaire, fact sheet and self-referral information will be provided by mail or email.

OTHER

Standard Care

Demographic and quality of life questionnaires; standard care provided by participants' GPs

Sponsors & Collaborators

  • Retired Teachers of Ontario Foundation

    collaborator UNKNOWN

  • Interior Health

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Kathy Rush, PhD · University of British Columbia- Okanagan

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-11
Primary Completion
2019-07-02
Completion
2019-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485872 on ClinicalTrials.gov